Pacific Biosciences Of California | PACB - Selling And Administration Expenses


Pacific Biosciences Of California reported $37.24M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Agilent USD 476M 48M Dec/2025
Bruker USD 247.2M 4.7M Dec/2025
Danaher USD 2.03B 35M Dec/2025
General Electric Aerospace USD 1.58B 385M Dec/2025
Illumina USD 283M 27M Dec/2025
Myriad Genetics USD 122.3M 6.7M Dec/2025
Pacific Biosciences Of California USD 37.24M 25.68M Dec/2025
Quidel USD 194.4M 7.5M Dec/2025
Revvity USD 251.73M 9.82M Dec/2025
Roche Holding CHF 7.28B 3.99B Dec/2025
Standard Biotools USD 21.55M 5.05M Dec/2025
Thermo Fisher Scientific USD 1.98B 182M Dec/2025
Waters USD 240.01M 25.78M Dec/2025